Ribon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ribon Therapeutics's estimated annual revenue is currently $14.4M per year.
- Ribon Therapeutics's estimated revenue per employee is $155,000
- Ribon Therapeutics's total funding is $184M.
Employee Data
- Ribon Therapeutics has 93 Employees.
- Ribon Therapeutics grew their employee count by -3% last year.
Ribon Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Corporate Development | Reveal Email/Phone |
2 | Senior Director Clinical Science, Clinical Development | Reveal Email/Phone |
3 | Director | Reveal Email/Phone |
4 | Director, GxP Quality | Reveal Email/Phone |
5 | Clinical Medical Director | Reveal Email/Phone |
6 | Senior Manager Accounting & Reporting | Reveal Email/Phone |
7 | Executive Office Manager | Reveal Email/Phone |
8 | Sr. Clinical Operations Associate | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Ribon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Ribon Therapeutics?
Ribon Therapeutics is a biotech company focused on developing first-in-class therapeutics targeting mono(ADP-ribosyl)ating PARPs for cancer.
keywords:N/A
$184M
Total Funding
93
Number of Employees
$14.4M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ribon Therapeutics News
2022-03-30 - Ribon Therapeutics Announces Initiation of Phase 1b/2 Study ...
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular...
2022-03-22 - Ribon initiates Phase I trial of atopic dermatitis treatment
Ribon Therapeutics has commenced the healthy volunteer segment of its first-in-human Phase I clinical trial to analyse the potential of its...
2022-03-22 - Ribon Therapeutics Initiates First-in-Human Phase 1 Clinical ...
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13M | 93 | 9% | N/A |
#2 | $9.3M | 93 | 2% | N/A |
#3 | $19.5M | 93 | 0% | N/A |
#4 | $13.5M | 93 | N/A | N/A |
#5 | $15.3M | 93 | N/A | N/A |